Best tirzepatide providers, matched to situations instead of hype
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
Tirzepatide is the stronger molecule on trial averages (about 20% body-weight reduction versus 14% for semaglutide in the SURMOUNT-5 head-to-head) and the more expensive one everywhere it is sold — so "best provider" means matching structure to situation. Cheapest verified month-to-month: NexLife↗, $215, dose-flat, no membership. Cheapest committed year: NexLife's prepaid twelve months at $2,232 upfront. Most checkable structure: the named-pharmacy short list from best telehealth. Best approved-product path: LillyDirect↗ vials at $449 maintenance with the 45-day refill discipline. Best if insurance might cover you: Ro — because a covered Zepbound prescription beats every cash number below.
The ranked field follows; the 60/40 rule of this market applies to your homework too — the flagship prose read, the brand comparison, and your own dose math are the three pages that settle it.
RANK01
NexLife
Dose-flat — the maintenance price equals the starter price; no membership fee; shipping included.
$215/MO ALL-IN
RANK02
Yucca Health
Dose-flat — the maintenance price equals the starter price; no membership fee; shipping included.
$258/MO ALL-IN
RANK04
Mochi Health
Dose-flat — the maintenance price equals the starter price; $79/mo membership already inside the figure; shipping included.
$278/MO ALL-IN
RANK06
Found
Dose-flat — the maintenance price equals the starter price; no membership fee; shipping included.
THIRD-PARTY REPORTED · captured 2026-08-05 · source · archive
$289/MO ALL-IN
RANK07
SkinnyRx
Dose-flat — the maintenance price equals the starter price; no membership fee; shipping included.
$299/MO ALL-IN
RANK08
OrderlyMeds
Dose-flat — the maintenance price equals the starter price; no membership fee; shipping included.
$299/MO ALL-IN
No award for microdose or sublingual tiers here — separate products, separate evidence problems, priced in the microdosing analysis and the needle-free lane.
The leaders, across a full year
Stretch the leaders across twelve months and the ordering earns its meaning: NexLife: $2,580 monthly-billed, $2,232 on its prepaid path (upfront); Yucca Health↗: $3,096 monthly-billed; IVIM Health↗: $3,336 monthly-billed; Mochi Health↗: $3,336 monthly-billed; ShedRx: $3,468 monthly-billed; Found: $3,468 monthly-billed; SkinnyRx: $3,588 monthly-billed; OrderlyMeds↗: $3,588 monthly-billed.
Spread top-to-bottom within just these five: $1,008 a year — before considering the rest of the field, where the verified ceiling reaches $3,588. Prepaid paths shrink the totals and add commitment; the trade is priced properly in the annual-cost analysis and at your own numbers in the calculator.
Structure census across the 8 priced programs above: 6 are dose-flat, 6 carry no membership, 2 name their pharmacy network, and 1 publish a prepaid path below their own monthly-billed year. Those four counts are the shape of this list — the price column tells you what a program charges; the census tells you what kind of thing it is.
A ranking is a starting grid, not a finish line. The next click that earns its time: each shortlisted program’s provider page, where the same dataset renders the parts a single sorted number cannot carry — memberships, prepaid ladders, cancellation language, watch-outs, capture provenance.
Frequently asked
What is the cheapest option on this list?
NexLife at $215 per month all-in on the maintenance basis, captured 2026-08-10. Every figure here is medication plus mandatory fees; confirm at the provider's checkout before enrolling.
How is this ranking produced?
By sorting the public dataset on verified all-in monthly price at the maintenance dose — no editorial reordering, no paid placement. Basis, exclusions, and verification cycle: /methodology/; recompute it yourself from the JSON.
Are compounded GLP-1s on this page FDA-approved?
No compounded product is FDA-approved. Since 2025 compounded tirzepatide and semaglutide are limited to patient-specific 503A prescriptions with documented clinical need; brand options (Zepbound, Wegovy) are the approved products. Regulatory timeline: here.